HeartSciences Inc

HSCSHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:59 PM ET

2.30-0.10 (-4.18%)

2026-11-11 23:16 CET

Market cap

11.90 USD m

Revenue, TTM

0.00 USD m

Net income, TTM

-10.26 USD m

Free cash flow, TTM

-6.80 USD m

EPS diluted, TTM

-3.20

P/E

Compare

Price

HSCS against its 20, 50 and 200-day averages

2050200miss

56.3% under the 52-week high of 5.25 on 21 Sep 2026. 52-week low 1.63 on 29 May 2026. Last 15 sessions, 77.0% high to low

Volume 1.11× normal · the line is the 50-bar volume average

Profile

HSCS

52-week range, 19% of the way up

1.635.25

HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. The firm offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded on August 16, 2007 and is headquartered in Southlake, TX.

Employees	14
IPO	Jun 15, 2022
Beta	1.86
ATR, 14d	0.40
Rel volume	1.11
Short float	3.00%
Insider own	16.60%
Inst own	3.38%

Snapshot

6 groups

Valuation

Index	-
Market Cap	11.40M
Enterprise Value	15.37M
Income	-10.26M
Sales	0.00M
Book/sh	-0.52
Cash/sh	0.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	14
IPO	Jun 15, 2022

Ratios

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	380.10
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.05
Current Ratio	0.12
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

Earnings

EPS (ttm)	-3.20
EPS next Y	-1.75
EPS next Q	-0.62
EPS this Y	25.90%
EPS next Y	28.86%
EPS next 5Y	-
EPS past 3/5Y	64.81% 32.51%
Sales past 3/5Y	-5.70% -29.95%
EPS Y/Y TTM	61.44%
Sales Y/Y TTM	-27.70%
EPS Q/Q	45.16%
Sales Q/Q	10.53%
Earnings	Sep 16 BMO
EPS/Sales Surpr.	-19.44% -

Ownership

Insider Own	16.60%
Insider Trans	0.00%
Inst Own	3.38%
Inst Trans	9.00%
ROA	-201.67%
ROE	-1851.90%
ROIC	-
Gross Margin	-2908.87%
Oper. Margin	-209733.08%
Profit Margin	-227024.23%
SMA20	-24.70%
SMA50	-35.62%
SMA200	-14.69%
Trades	-

Technical

Shs Outstand	4.97M
Shs Float	4.14M
Short Float	3.00%
Short Ratio	0.76
Short Interest	0.12M
52W High	5.25 -56.29%
52W Low	1.63 40.80%
Volatility	18.10% 11.77%
ATR (14)	0.40
RSI (14)	34.57
Beta	1.86
Rel Volume	1.11
Avg Volume	164.14K
Volume	181,943

Performance

Perf Week	-25.97%
Perf Month	-25.73%
Perf Quarter	11.41%
Perf Half Y	21.43%
Perf YTD	-25.73%
Perf Year	-22.47%
Perf 3Y	-85.44%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	12.00
Prev Close	2.39
Price	2.30
Change %	-4.18%

Peers

Mkt cap

Ticker	Company	Mkt cap
BEAT	HeartBeam Inc	23.16M
IRTC	iRhythm Holdings Inc	2.98B
PMI	Picard Medical Inc	19.77M
CVRX	CVRx Inc	19.95M
CDIO	Cardio Diagnostics Holdings Inc	5.68M
BJDX	Bluejay Diagnostics Inc	3.13M
INBS	Intelligent Bio Solutions Inc	6.96M
NUWE	Nuwellis Inc	2.99M
BFLY	Butterfly Network Inc	1.91B
HTFL	Heartflow Inc	5.14B

Ticker

Company

Mkt cap

BEAT

HeartBeam Inc

23.16M

IRTC

iRhythm Holdings Inc

2.98B

PMI

Picard Medical Inc

19.77M

CVRX

CVRx Inc

19.95M

CDIO

Cardio Diagnostics Holdings Inc

5.68M

BJDX

Bluejay Diagnostics Inc

3.13M

INBS

Intelligent Bio Solutions Inc

6.96M

NUWE

Nuwellis Inc

2.99M

BFLY

Butterfly Network Inc

1.91B

HTFL

Heartflow Inc

5.14B

Held by

AUM

Ticker	Company	AUM
VXF	Vanguard Extended Market Index ETF	AUM: 30.47B

Ticker

Company

AUM

VXF

Vanguard Extended Market Index ETF

AUM: 30.47B

News

latest 14 of 194

Oct-21-26 08:30AMHeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining (GlobeNewswire) +13.74%
Oct-06-26 09:12AMFortitude Doubles Down on Zcash Mining With $100M BITMAIN Commitment (CryptoProwl) -13.53%
08:30AMHeartSciences Receives FDA 510(k) Clearance for its MyoVista wavECGTM Device (GlobeNewswire)
Oct-05-26 06:10PMFortitude Secures Priority Supply Allocation for BITMAINs Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of DCG Credit Facility and Available ZEC Funding from DCG (Business Wire)
Sep-29-26 05:30PMFortitude Appoints Kimberly Pittman as Chief Legal Officer (Business Wire) -8.58%
Sep-23-26 05:30PMFortitude Announces Amendment to Existing DCG Credit Facility, Increasing Commitment by $24 Million and Providing for Future Funding in ZEC (Business Wire)
Sep-17-26 02:14PMFormer Hut 8 CEO To Lead Crypto Miner Fortitude (CryptoProwl) +27.70%
08:00AMFortitudeAppoints Jaime Leverton as Chief Executive Officer (Business Wire)
Sep-15-26 09:25AMHeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update (GlobeNewswire)
Aug-20-26 07:30AMFortitude Provides Second Quarter 2026 Financial and Operating Highlights (Business Wire)
Aug-19-26 09:00AMFortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration (GlobeNewswire) +19.48%
Jul-30-26 07:30AMFortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem (Business Wire)
Jul-29-26 09:00AMHeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results (GlobeNewswire)
Jul-28-26 07:31AMZcash Miner Fortitude Powers Up Nebraska Facility as It Eyes Public Listing (decrypt) -10.67%

Key figures

Revenue, TTM	0.00
Net income, TTM	-10.26
EPS diluted, TTM	-3.20
EBIT, TTM	-9.48
Free cash flow, TTM	-6.80
Gross margin	-2,908.87%
Operating margin	-209,733.08%
Net margin	-227,024.23%
Market cap	11.90
P/E	-
Sales Y/Y, TTM	-27.70%

USD millions. TTM from the statement feed.

Quarterly earnings

actual against estimate

Period	Reported	EPS act	EPS est	EPS rep	Sales act	Sales est	Analysts
2026Q1	2026-09-16	-0.860	-0.720	-0.860	0.00	0.00	1
2025Q4	2026-07-22	-0.510	-0.660	-0.863	0.00	0.00	1
2025Q3	2026-03-12	-0.710	-0.880	-0.628	0.00	0.00	2
2025Q2	2025-12-11	-0.850	-1.275	-0.845	0.00	0.00	2
2025Q1	2025-09-11	-1.510	-1.875	-1.577	0.00	0.00	2
2024Q4	2025-07-02	-1.910	-1.780	-1.881	0.00	0.00	1
2024Q3	2025-03-13	-2.545	-2.305	-2.572	0.00	0.00	2
2024Q2	2024-12-17	-2.270	-2.335	-2.270	0.00	0.00	2
2024Q1	2024-09-12	-2.605	-2.305	-2.638	0.00	0.00	2
2023Q4	2024-07-17	-2.900	-3.500	-2.729	0.00	0.05	2
2023Q3	2024-03-14	-3.000	-6.000	-3.056	0.01	0.00	1
2023Q2	2023-12-15	-16.000	-12.000	-15.983	0.00	0.00	1
2023Q1	2023-09-27	-13.000	-14.000	-13.230	0.00	0.00	1
2022Q4	2023-06-28	-17.000	-16.000	-16.133	0.00	0.00	2
2022Q3	2023-06-07	-16.000	-	-16.074	0.00	-	2
2022Q2	2023-03-26	-22.000	-	-22.002	0.00	-	1

Annual earnings

Period	EPS act	EPS est	EPS rep	Sales act	Sales est
2021FY	-145	-	-1.776	0.01	-
2022FY	-80.000	-77.500	-79.923	0.00	0.00
2023FY	-25.370	-20.000	-18.737	0.01	0.05
2024FY	-9.255	-9.090	-9.340	0.00	0.00
2025FY	-3.320	-3.470	-3.480	0.00	0.00
2026FY	-	-2.460	-	-	0.02
2027FY	-	-1.750	-	-	3.15

Estimate revisions

last 14 periods

Period	Type	Date	Estimates	Down	Mean	Low	High
2026Q2	S	2026-09-16	1	0	0.00	0.00	0.00
2026Q2	S	2026-07-22	1	0	0.00	0.00	0.00
2026Q2	S	2026-06-30	1	0	0.00	0.00	0.00
2026Q2	S	2026-06-26	1	0	0.10	0.10	0.10
2026Q2	S	2026-06-03	2	0	0.05	0.00	0.10
2026Q2	S	2026-06-01	2	1	0.05	0.00	0.10
2026Q2	S	2026-03-20	2	2	0.05	0.00	0.10
2026Q2	S	2026-03-18	2	1	0.10	0.00	0.20
2026Q2	S	2026-03-12	2	0	0.15	0.10	0.20
2026Q2	S	2025-12-11	2	0	0.15	0.10	0.20
2026Q2	S	2025-11-11	2	0	0.15	0.10	0.20
2026Q2	S	2025-11-10	2	0	0.15	0.10	0.20
2026Q2	S	2025-11-09	2	0	0.15	0.10	0.20
2026Q2	S	2025-11-08	2	0	0.15	0.10	0.20

Estimate history

Period	2019	2020	2021	2022	2023	2024	2025	TTM
EPS, annual	-38.644	-24.864	-1.776	-79.923	-18.737	-9.342	-3.482	-3.2007
EPS, quarterly	-2.638	-2.27	-2.572	-1.881	-1.577	-0.845	-0.628	-0.863	-0.865
Period	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Sales, annual	0.064	0.026	0.014	0.005	0.019	0.004	0.004	0
Period	2019	2020	2021	2022	2023	2024	2025	TTM
Sales, quarterly	0	0	0	0.004	0.002	0.002	0	0	0.002
Period	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Shares, annual	0.099	0.099	2.718	0.101	0.677	1.119	3.188	3.905
Period	2019	2020	2021	2022	2023	2024	2025	MRQ
Shares, quarterly	0.906	0.948	1.032	1.119	2.281	3.071	3.184	3.188	3.905
Period	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26

Income statement, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY
Total Revenue	0.00	0.00	0.00	0.02	0.01	0.01	0.03	0.06
Cost of Goods Sold Incl. D&A	0.14	0.13	0.13	0.10	0.03	0.03	0.04	0.11
Gross Profit	-0.13	-0.13	-0.13	-0.08	-0.02	-0.02	-0.02	-0.05
Selling, General and Administrative Excl. Other	9.35	8.28	8.23	6.22	6.09	4.69	2.55	3.77
Research and Development	2.75	2.84	4.39	2.88	2.46	3.00	1.71	2.04
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	-9.48	-8.41	-8.35	-6.31	-6.11	-4.71	-2.57	-3.82
Interest Expense	0.80	0.75	0.50	0.35	0.24	0.37	0.13	0.00
Unusual Expense	0.00	0.00	0.00	-0.05	-0.00	-0.25	-0.25	0.00
Net Income Before Taxes	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Income Taxes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Consolidated Net Income	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Net Income From Continuing Operations	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Net Income	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
EPS (Recurring)	-2.80	-3.48	-9.34	-18.85	-79.94	-1.84	-26.64	-38.64
EPS (Basic, Before Extraordinaries)	-3.20	-3.48	-9.34	-18.74	-79.92	-1.78	-24.86	-38.64
EPS (Diluted)	-3.20	-3.48	-9.34	-18.74	-79.92	-1.78	-24.86	-38.64
EBITDA	-9.34	-8.28	-8.22	-6.21	-6.09	-4.68	-2.53	-3.75
Non-Operating Income (Expense)	0.02	0.02	0.09	0.00	0.00	0.00	-0.00	0.01
Other After Tax Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock Option Compensation Expense	1.31	1.31	0.25	0.41	0.25	0.07	0.03	0.14
Price To Sales Ratio	1,769.93	1,185.36	756.00	175.12	1,370.12	-	-	-
Gross Margin	-2,908.87	-2,982.15	-2,884.74	-444.16	-476.91	-139.73	-72.93	-71.83
Operating Margin	-209,733.08	-194,787.38	-192,013.13	-33,901.99	-118,698.33	-32,765.60	-10,030.18	-5,949.00
Net Margin	-227,024.23	-211,666.47	-201,499.52	-35,511.87	-123,384.27	-33,592.57	-9,577.29	-5,937.99
Shares Outstanding	3.90	3.19	1.12	0.68	0.10	2.72	0.10	0.10
Market Capitalization	11.90	11.90	3.79	6.25	7.41	7.41	-	-

Income statement, quarterly

Currency USD, millions
Metric	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2
Total Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of Goods Sold Incl. D&A	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Gross Profit	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03
Selling, General and Administrative Excl. Other	2.91	2.50	1.90	2.04	1.84	1.89	2.34	1.95
Research and Development	0.91	0.48	0.64	0.73	1.00	0.93	1.03	1.20
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	-2.94	-2.54	-1.93	-2.07	-1.87	-1.92	-2.37	-1.99
Interest Expense	0.24	0.23	0.06	0.28	0.18	0.18	0.18	0.12
Unusual Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income Before Taxes	-3.17	-2.75	-1.99	-2.35	-2.05	-2.09	-2.54	-2.08
Income Taxes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Consolidated Net Income	-3.17	-2.75	-1.99	-2.35	-2.05	-2.09	-2.54	-2.08
Net Income From Continuing Operations	-3.17	-2.75	-1.99	-2.35	-2.05	-2.09	-2.54	-2.08
Net Income	-3.17	-2.75	-1.99	-2.35	-2.05	-2.09	-2.54	-2.08
EPS (Recurring)	-0.86	-0.86	-0.63	-0.85	-1.58	-1.88	-2.57	-2.27
EPS (Basic, Before Extraordinaries)	-0.86	-0.86	-0.63	-0.85	-1.58	-1.88	-2.57	-2.27
EPS (Diluted)	-0.86	-0.86	-0.63	-0.85	-1.58	-1.88	-2.57	-2.27
EBITDA	-2.90	-2.50	-1.90	-2.04	-1.84	-1.89	-2.34	-1.95
Non-Operating Income (Expense)	0.00	0.01	0.01	0.00	0.00	0.01	0.01	0.02
Other After Tax Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock Option Compensation Expense	0.17	0.32	0.38	0.44	0.17	0.10	0.05	0.04
Price To Sales Ratio	1,769.93	1,439.53	1,178.23	978.26	650.72	897.34	-	183.49
Gross Margin	-1,580.38	-	-	-1,282.51	-1,607.11	-661.86	-	-
Operating Margin	-139,956.67	-	-	-85,713.23	-98,637.84	-44,147.10	-	-
Net Margin	-151,064.00	-	-	-97,179.37	-108,157.58	-48,145.52	-	-
Shares Outstanding	3.90	3.19	3.18	3.07	2.28	1.12	1.03	0.95
Market Capitalization	11.90	6.21	10.27	8.08	6.04	3.79	2.95	2.69

Balance sheet, annual

Currency USD, millions
Metric	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY
Cash & Short Term Investments	1.66	1.10	5.81	1.66	0.92	0.72	0.50
Short Term Receivables	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.66	0.65	0.63	0.68	0.67	0.75	0.86
Other Current Assets	0.12	0.13	0.22	0.18	0.09	0.16	0.18
Total Current Assets	2.44	1.88	6.66	2.52	1.68	1.64	1.54
Net Property, Plant & Equipment	0.31	0.44	0.56	0.59	0.16	0.29	0.42
Total Investments and Advances	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	2.37	1.62	1.59	0.00	0.00	0.00	0.00
Other Assets	0.15	0.29	0.69	0.18	0.25	0.00	0.00
Total Assets	5.26	4.22	9.50	3.29	2.09	1.93	1.96
Short Term Debt Incl. Current Port. of LT Debt	3.76	2.67	0.60	0.53	1.72	0.49	0.44
Accounts Payable	0.32	0.32	0.45	0.63	0.69	0.34	0.36
Other Current Liabilities	0.78	0.71	0.70	0.67	1.05	0.42	0.34
Total Current Liabilities	4.86	3.70	1.75	1.83	3.47	1.25	1.14
Long Term Debt	0.18	0.31	0.43	1.04	4.44	2.59	0.50
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.19	0.23	0.00	0.00
Total Liabilities	5.04	4.02	2.19	3.06	8.15	3.84	1.64
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Equity	0.23	0.20	7.32	0.23	-6.06	-1.91	0.32
Total Shareholders Equity	0.23	0.21	7.32	0.23	-6.06	-1.91	0.32
Accumulated Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity	0.23	0.21	7.32	0.23	-6.06	-1.91	0.32
Total Liabilities & Stockholders Equity	5.26	4.22	9.50	3.29	2.09	1.93	1.96
Book Value Per Share	0.07	0.18	10.81	2.27	-2.23	-19.37	3.19
Tangible Book Value Per Share	-0.67	-1.26	8.47	2.27	-2.23	-19.37	3.19
Full-Time Employees	14	15	15	12	12	-	-
Price to Book Ratio	-4.60	2.03	0.85	-28.69	-28.69	-	-
Return on Assets	-192.75	-127.72	-103.28	-236.36	-240.40	-126.30	-
Return on Equity	-4,239.90	-233.04	-175.02	-	-	-	-
Return on Invested Capital	-2,276.58	-1,686.60	-85.21	-501.57	-	-359.88	-468.11
Quick Ratio	0.37	0.33	3.44	1.01	0.29	0.71	0.60
Current Ratio	0.50	0.51	3.80	1.38	0.49	1.31	1.35

Cash flow, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY
Net Income	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83	-2.45	-3.81
Depreciation	0.13	0.13	0.13	0.10	0.03	0.03	0.03	0.06
Other Funds (Non Cash)	3.47	2.67	0.71	0.94	0.38	0.03	-0.22	0.10
Funds from Operations	-6.65	-6.35	-7.93	-5.57	-5.95	-4.77	-2.64	-3.64
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	-0.14	-1.08	0.52	-0.50	0.17	1.12	0.19	-0.20
Cash from Operating Activities	-6.79	-7.43	-7.41	-6.07	-5.77	-3.64	-2.45	-3.84
Capital Expenditures	-0.32	-0.04	-0.03	-0.13	-0.02	-0.00	-0.00	-0.01
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Purchase or Sale of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchase of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale Or Maturity of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Uses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Sources	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Investing Activities	-0.32	-0.04	-0.03	-0.13	-0.02	-0.00	-0.00	0.01
Cash Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Capital Stock	1.94	5.72	1.15	10.30	6.93	0.00	0.20	1.18
Repurchase of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	1.94	5.72	1.15	10.30	6.93	0.00	0.20	1.18
Proceedsfrom Stock Options	1.94	5.72	1.15	10.30	6.93	0.00	0.20	1.18
Issuance or Reduction of Debt, Net	2.42	2.31	1.85	0.04	-0.40	3.84	2.48	0.63
Change in Long Term Debt	2.42	2.31	1.85	0.04	-0.40	3.84	2.23	0.38
Issuance of Long Term Debt	3.00	3.00	1.85	0.33	0.00	3.84	2.23	0.40
Reduction of Long Term Debt	-0.58	-0.69	0.00	-0.29	-0.40	0.00	0.00	-0.02
Net Financing Active Other Cash Flow	0.00	0.00	-0.26	0.00	0.00	0.00	0.00	0.00
Other Financing Activities Uses	0.00	0.00	-0.26	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	4.35	8.03	2.73	10.34	6.53	3.84	2.68	1.81
Net Change in Cash	-2.76	0.56	-4.71	4.15	0.74	0.19	0.23	-2.02
Free Cash Flow	-6.80	-7.43	-7.42	-6.13	-5.79	-3.65	-2.45	-3.85
Deferred Taxes & Investment Tax Credit	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance sheet, quarterly

Currency USD, millions
Metric	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4
Cash & Short Term Investments	0.03	1.66	3.40	1.95	2.79	1.10
Short Term Receivables	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.40	0.66	0.66	0.66	0.65	0.65
Other Current Assets	0.25	0.12	0.22	0.48	0.46	0.13
Total Current Assets	0.69	2.44	4.28	3.09	3.90	1.88
Net Property, Plant & Equipment	0.27	0.31	0.34	0.37	0.40	0.44
Total Investments and Advances	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	2.65	2.37	2.11	1.83	1.62	1.62
Other Assets	0.13	0.15	0.82	0.71	0.52	0.29
Total Assets	3.74	5.26	7.55	6.00	6.44	4.22
Short Term Debt Incl. Current Port. of LT Debt	3.87	3.76	3.23	0.63	1.67	2.67
Accounts Payable	1.02	0.32	0.41	0.32	0.28	0.32
Other Current Liabilities	0.74	0.78	0.62	0.62	1.07	0.71
Total Current Liabilities	5.63	4.86	4.27	1.57	3.01	3.70
Long Term Debt	0.14	0.18	0.63	0.25	0.28	0.31
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	5.77	5.04	4.90	1.81	3.30	4.02
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00	0.00	0.00
Common Equity	-2.03	0.23	2.65	4.18	3.14	0.20
Total Shareholders Equity	-2.03	0.23	2.65	4.18	3.14	0.21
Accumulated Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity	-2.03	0.23	2.65	4.18	3.14	0.21
Total Liabilities & Stockholders Equity	3.74	5.26	7.55	6.00	6.44	4.22
Book Value Per Share	-0.52	0.07	0.83	1.36	1.38	0.18
Tangible Book Value Per Share	-1.20	-0.67	0.17	0.77	0.67	-1.26
Full-Time Employees	-	14	-	-	-	15
Price to Book Ratio	-4.60	2.34	2.37	2.22	17.05	2.03
Return on Assets	-201.67	-192.75	-128.00	-131.22	-119.88	-127.72
Return on Equity	-1,851.90	-4,239.90	-382.32	-220.42	-193.24	-233.04
Return on Invested Capital	-	-685.05	-60.42	-53.07	-60.04	-402.99
Quick Ratio	0.05	0.37	0.85	1.55	1.08	0.33
Current Ratio	0.12	0.50	1.00	1.97	1.29	0.51

Cash flow, quarterly

Currency USD, millions
Metric	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4
Net Income	-3.17	-2.75	-1.99	-2.35	-2.05	-2.09
Depreciation	0.03	0.03	0.03	0.03	0.03	0.03
Other Funds (Non Cash)	1.09	1.17	0.48	0.73	0.28	0.37
Funds from Operations	-2.05	-1.54	-1.48	-1.59	-1.74	-1.70
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	0.73	-0.13	0.01	-0.75	-0.21	0.11
Cash from Operating Activities	-1.32	-1.68	-1.46	-2.33	-1.95	-1.59
Capital Expenditures	-0.28	0.00	-0.03	-0.02	-0.00	-0.01
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.00	0.00	0.00
Purchase or Sale of Investments	0.00	0.00	0.00	0.00	0.00	0.00
Purchase of Investments	0.00	0.00	0.00	0.00	0.00	0.00
Sale Or Maturity of Investments	0.00	0.00	0.00	0.00	0.00	0.00
Other Uses	0.00	0.00	0.00	0.00	0.00	0.00
Other Sources	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Investing Activities	-0.28	0.00	-0.03	-0.02	-0.00	-0.01
Cash Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Dividends (Cash Flow)	-	-	0.00	-	-	-
Change in Capital Stock	0.01	0.00	0.00	1.93	3.80	0.17
Repurchase of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	0.01	0.00	0.00	1.93	3.80	0.17
Proceedsfrom Stock Options	0.01	0.00	0.00	1.93	3.80	0.17
Issuance or Reduction of Debt, Net	-0.04	-0.06	2.94	-0.42	-0.15	0.00
Change in Long Term Debt	-0.04	-0.06	2.94	-0.42	-0.15	0.00
Issuance of Long Term Debt	0.00	0.00	3.00	0.00	0.00	0.00
Reduction of Long Term Debt	-0.04	-0.06	-0.06	-0.42	-0.15	0.00
Net Financing Active Other Cash Flow	0.00	0.00	0.00	0.00	0.00	-0.07
Other Financing Activities Uses	0.00	0.00	0.00	0.00	0.00	-0.07
Cash from Financing Activities	-0.03	-0.06	2.94	1.51	3.65	0.10
Net Change in Cash	-1.63	-1.74	1.45	-0.84	1.69	-1.50
Free Cash Flow	-1.32	-1.68	-1.45	-2.35	-1.95	-1.59

Revenue breakdown

Finance Services	2024: 4.35K 2025: 4.32K
United States	2024: 4.35K 2025: 4.32K

Short interest

shares short against float, oldest to newest

Settlement	Of float	Shares short	Float	Avg volume
2026-10-30	3.00%	0.1M	4.1M	163.37K
2026-10-15	1.53%	0.1M	4.1M	156.26K
2026-09-30	0.73%	0.0M	3.9M	110.23K
2026-09-15	1.04%	0.0M	3.8M	2.31M
2026-08-31	3.68%	0.1M	3.1M	2.26M
2026-08-14	1.63%	0.1M	3.1M	2.27M
2026-07-31	2.21%	0.1M	3.4M	2.27M
2026-07-15	3.07%	0.1M	2.5M	2.30M
2026-06-30	4.89%	0.1M	2.5M	2.26M
2026-06-15	1.84%	0.1M	3.1M	29.45K
2026-05-29	1.40%	0.0M	3.1M	20.03K
2026-05-15	1.21%	0.0M	3.1M	18.29K
2026-04-30	1.02%	0.0M	3.1M	17.21K
2026-04-15	0.93%	0.0M	3.1M	16.79K
2026-03-31	1.13%	0.0M	3.1M	21.04K
2026-03-13	1.04%	0.0M	3.1M	39.65K
2026-02-27	1.23%	0.0M	3.1M	42.90K
2026-02-13	0.96%	0.0M	3.1M	47.93K
2026-01-30	1.34%	0.0M	3.1M	51.18K
2026-01-15	0.98%	0.0M	3.1M	49.24K

Option chain

expiry 2026-11-11

Type	Strike	Bid	Ask	Last	IV	Open int	Volume	Delta	Theta	Vega
No option chain for this symbol.

Type

Strike

Bid

Ask

Last

Open int

Volume

Delta

Theta

Vega

No option chain for this symbol.

Latest SEC filings

Filed	Form	Description	Period	Link
2026-11-10	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-10	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-10	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-09	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-06	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-06	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-06	8-K	Current report	2026-11-06	SEC
2026-11-05	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-04	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-03	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-11-02	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-30	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-29	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-28	SCHEDULE 13G			SEC
2026-10-28	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-27	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-26	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-26	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-23	SCHEDULE 13D/A			SEC
2026-10-21	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-19	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-19	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-19	DEFM14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-15	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-09	424B5			SEC
2026-10-06	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-06	8-K	Current report	2026-10-06	SEC
2026-10-06	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-06	PRER14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-02	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC

Filed

Form

Description

Period

Link

2026-11-10

DEFA14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Month	Bought	Buys	Sold	Sells
2026-11	0	0	0	0
2026-10	0	0	0	0
2026-09	0	0	0	0
2026-08	0	0	0	0
2026-07	0	0	0	0
2026-06	0	0	0	0
2026-05	0	0	0	0
2026-04	0	0	0	0
2026-03	0	0	0	0
2026-02	0	0	0	0
2026-01	0	0	0	0
2025-12	0	0	0	0
2025-11	0	0	0	0

Manager	% owned
TFB Advisors LLC	0.62%
GEODE CAPITAL MANAGEMENT, LLC	0.62%
VANGUARD CAPITAL MANAGEMENT LLC	0.55%
VANGUARD FIDUCIARY TRUST CO	0.52%
Tradition Wealth Management, LLC	0.51%
CITADEL ADVISORS LLC	0.44%
Astoria Strategic Wealth, Inc.	0.39%
CITIGROUP INC	0.28%
UBS Group AG	0.27%
Tower Research Capital LLC	0.05%

Fund	% owned
VANGUARD EXTENDED MARKET INDEX FUND	0.55%
Fidelity Extended Market Index Fund	0.41%
Fidelity Series Total Market Index Fund	0.07%
Fidelity Total Market Index Fund	0.06%